Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Moderna, Inc. - Common Stock
(NQ:
MRNA
)
31.09
-2.49 (-7.42%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 27, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna, Inc. - Common Stock
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
99
100
Next >
Nasdaq Turns Lower; US Retail Sales Top Estimates
December 14, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.04% to 37,105.00 while the NASDAQ fell 0.44% to 14,669.25. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Eye 7-Day Winning Streak As Mortgage Rates Fall Below 7%, Yields Tumble: What's Driving Markets Thursday?
December 14, 2023
It’s shaping up to be a positive Thursday on Wall Street, with risk sentiment remaining robust after the Federal Reserve effectively opened the door to rate cuts in 2024.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data For MRNA-1345, The Company’s Investigational Respiratory Syncytial Virus (RSV) Vaccine
December 14, 2023
Via
ACCESSWIRE
Why Are Bank Stocks Up Today?
December 14, 2023
Bank stocks are up today and investors wonder why have come to the right place as we have a detailed explanation for the rally!
Via
InvestorPlace
2 Big Stocks Making Big Moves Thursday
December 14, 2023
One is rising while the other's on the decline. Here's why.
Via
The Motley Fool
What's Going On With Moderna (MRNA) Stock?
December 13, 2023
Moderna Inc (NASDAQ: MRNA) shares are trading lower by 4.5% to $74.50 during Wednesday's session.
Via
Benzinga
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 14, 2023
Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales...
Via
Benzinga
Jabil Posts Upbeat Earnings, Joins Moderna, Rivian Automotive And Other Big Stocks Moving Higher On Thursday
December 14, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining around 75 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Moderna's Options Frenzy: What You Need to Know
December 08, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Moderna Stock In The Last 5 Years
December 05, 2023
Via
Benzinga
Peering Into Moderna's Recent Short Interest
December 04, 2023
Via
Benzinga
Why Is SOFI Stock Up Today?
December 14, 2023
SoFi Technologies stock is up on Thursday as investors celebrate news that the Federal Reserve won't increase interest rates.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
Opendoor (OPEN) Stock Jumps on Analyst Upgrade
December 14, 2023
Opendoor Technologies stock is rising higher on Thursday as investors in OPEN shares react to an upgrade from Keefe, Bruyette & Woods.
Via
InvestorPlace
Why Is Moderna (MRNA) Stock Up 11% Today?
December 14, 2023
Moderna stock is on the rise Thursday as investors in MRNA react to positive results from a skin cancer vaccine in a Phase 2b trial.
Via
InvestorPlace
Moderna Stock Is Soaring Today - Here's Why
December 14, 2023
Moderna Inc (NASDAQ: MRNA) and Merck & Co Inc (NYSE: MRK) announced follow-up data from the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study of mRNA-4157 (V940), an investigational individualized...
Via
Benzinga
Moderna And Merck Announce mRNA-4157 (V940) In Combination with Keytruda(R) (Pembrolizumab) Demonstrated Continued Improvement in Recurrence-Free Survival and Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following
December 14, 2023
Via
ACCESSWIRE
Stocks Hold Steady, Yields Decline As Fed Meeting Looms: What's Driving Markets Wednesday?
December 13, 2023
Midway through the trading day on Wall Street, calm reigns supreme as investors eagerly await the Federal Reserve’s decision on interest rates.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Pfizer Issues FY24 Forecast, Joins Target Hospitality, Southwest Airlines And Other Big Stocks Moving Lower On Wednesday
December 13, 2023
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 40 points on Wednesday. Shares of Pfizer Inc. (NYSE: PFE) shares fell sharply during Wednesday’s session after the company...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pfizer Stock Tumble Steepens As Seagen Guidance Update Disappoints
December 13, 2023
Pfizer's updated 2024 revenue figures, including Seagen, undercut the consensus target.
Via
Investor's Business Daily
3 Dirt-Cheap Stocks to Buy Hand Over Fist Before the End of the Year
December 13, 2023
These players could lift your portfolio when they rebound and over the long term.
Via
The Motley Fool
What's Going On With Moderna Stock Today?
December 12, 2023
Moderna Inc (NASDAQ: MRNA) announced changes to its operating model to bring focus to its short- and
Via
Benzinga
Moderna Announces Changes to Commercial Organization to Prepare for Multiple Product Launches in 2024 and 2025
December 12, 2023
Via
ACCESSWIRE
Merck and Moderna Initiate INTerpath-002, a Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) for Adjuvant Treatment of Patients with Certain Types of Resected Non-Small Cell Lung Cancer
December 11, 2023
From
Merck & Co., Inc.
Via
Business Wire
These 2 Stocks Are All-Stars in the Making
December 11, 2023
These exciting players look cheap today considering their future prospects.
Via
The Motley Fool
Vertex Pharmaceuticals Just Proved Something Big to Investors. Time to Buy?
December 10, 2023
The big biotech's shares have been on the rise this year.
Via
The Motley Fool
7 F-Rated Stocks to Sell in December
December 08, 2023
If you’re holding F-rated stocks to sell, it may be too late to salvage 2023, but you can still get back on track toward achieving your goals.
Via
InvestorPlace
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
December 07, 2023
Fifty-six percent of S&P 500 companies have shown positive performance in 2023 and 44% retreated Moderna Inc. (NASDAQ: MRNA) offers the highest upside potential (58%).
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event
December 07, 2023
Via
ACCESSWIRE
2024's Potential Stock Surprises: Goldman Sachs Unveils S&P 500 Laggards For Major Gains
December 06, 2023
Investors hunt for new opportunities in stocks that have been discounted & now present promising options for recovery.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Dirt Cheap Stocks You'll Regret Not Buying Before the New Year
December 04, 2023
Load up on these stocks while the price is right, and hold them for the long term.
Via
The Motley Fool
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.